90 related articles for article (PubMed ID: 17541941)
1. Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo.
Craig M; Ying C; Loberg RD
J Cell Biochem; 2008 Jan; 103(1):1-8. PubMed ID: 17541941
[TBL] [Abstract][Full Text] [Related]
2. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.
Collado B; Carmena MJ; Clemente C; Prieto JC; Bajo AM
Peptides; 2007 Sep; 28(9):1896-901. PubMed ID: 17544169
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
[TBL] [Abstract][Full Text] [Related]
6. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
7. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.
Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL
J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685
[TBL] [Abstract][Full Text] [Related]
8. DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.
Niewiarowska J; Sacewicz I; Wiktorska M; Wysocki T; Stasikowska O; Wagrowska-Danilewicz M; Cierniewski CS
Cancer Gene Ther; 2009 Sep; 16(9):713-22. PubMed ID: 19247396
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis.
Kimura YN; Watari K; Fotovati A; Hosoi F; Yasumoto K; Izumi H; Kohno K; Umezawa K; Iguchi H; Shirouzu K; Takamori S; Kuwano M; Ono M
Cancer Sci; 2007 Dec; 98(12):2009-18. PubMed ID: 17924976
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-1 alters tumor growth by stabilizing blood vessels or by promoting angiogenesis.
Satoh N; Yamada Y; Kinugasa Y; Takakura N
Cancer Sci; 2008 Dec; 99(12):2373-9. PubMed ID: 19018775
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL
Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
14. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
[TBL] [Abstract][Full Text] [Related]
15. [Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells in vivo].
Han YL; He DL; Luo Y; Cheng HP; Zhu GF
Zhonghua Nan Ke Xue; 2008 May; 14(5):439-44. PubMed ID: 18572865
[TBL] [Abstract][Full Text] [Related]
16. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
Evans S; Dizeyi N; Abrahamsson PA; Persson J
Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929
[TBL] [Abstract][Full Text] [Related]
17. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
Lee SO; Pinder E; Chun JY; Lou W; Sun M; Gao AC
Prostate; 2008 Jan; 68(1):85-91. PubMed ID: 18008330
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
